NOVOZYMES A/S/S Stock Price, News & Analysis (OTCMKTS:NVZMY)

$42.86
+0.09 (+0.21 %)
(As of 09/24/2019 05:18 AM ET)
Today's Range
$42.71
Now: $42.86
$43.15
50-Day Range
$39.97
MA: $42.53
$46.39
52-Week Range
$39.96
Now: $42.86
$55.5550
Volume10,025 shs
Average Volume23,350 shs
Market Capitalization$12.73 billion
P/E Ratio24.49
Dividend Yield1.17%
Beta0.76
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:NVZMY
CUSIPN/A
CIKN/A
Phone45-4446-0000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.28 billion
Cash Flow$1.7069 per share
Book Value$6.10 per share

Profitability

Net Income$511 million

Miscellaneous

Employees6,427
Market Cap$12.73 billion
Next Earnings Date10/23/2019 (Estimated)
OptionableNot Optionable

Receive NVZMY News and Ratings via Email

Sign-up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter.


NOVOZYMES A/S/S (OTCMKTS:NVZMY) Frequently Asked Questions

What is NOVOZYMES A/S/S's stock symbol?

NOVOZYMES A/S/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How often does NOVOZYMES A/S/S pay dividends? What is the dividend yield for NOVOZYMES A/S/S?

NOVOZYMES A/S/S declared an annual dividend on Thursday, February 7th. Investors of record on Friday, March 1st will be paid a dividend of $0.504 per share on Tuesday, March 19th. This represents a yield of 1.16%. The ex-dividend date of this dividend is Thursday, February 28th. View NOVOZYMES A/S/S's Dividend History.

How were NOVOZYMES A/S/S's earnings last quarter?

NOVOZYMES A/S/S (OTCMKTS:NVZMY) posted its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by $0.06. The biotechnology company earned $520.49 million during the quarter, compared to the consensus estimate of $556.19 million. NOVOZYMES A/S/S had a return on equity of 28.54% and a net margin of 22.31%. View NOVOZYMES A/S/S's Earnings History.

When is NOVOZYMES A/S/S's next earnings date?

NOVOZYMES A/S/S is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for NOVOZYMES A/S/S.

What is the consensus analysts' recommendation for NOVOZYMES A/S/S?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NOVOZYMES A/S/S in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NOVOZYMES A/S/S.

Has NOVOZYMES A/S/S been receiving favorable news coverage?

News headlines about NVZMY stock have trended somewhat negative recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. NOVOZYMES A/S/S earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for NOVOZYMES A/S/S.

Who are some of NOVOZYMES A/S/S's key competitors?

What other stocks do shareholders of NOVOZYMES A/S/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NOVOZYMES A/S/S investors own include ManpowerGroup (MAN), TeamHealth (TMH), Novo Nordisk A/S (NVO), DANSKE BK A/S/S (DNKEY), FOX (FOXA), Level One Bancorp (LEVL), Anadarko Petroleum (APC), Duke Energy (DUK), Emerson Electric (EMR) and Zayo Group (ZAYO).

Who are NOVOZYMES A/S/S's key executives?

NOVOZYMES A/S/S's management team includes the folowing people:
  • Mr. Peder Holk Nielsen, Pres & CEO (Age 63)
  • Dr. Prisca Havranek-Kosicek, CFO & Exec. VP of Corp. Functions (Age 44)
  • Mr. Thomas Videbaek, Exectuive VP & COO of Research, Innovation & Supply (Age 59)
  • Mr. Andrew Fordyce, Exec. VP of Food & Beverages (Age 56)
  • Mr. Anders Lund, Exec. VP of Household Care & Technical Industries (Age 46)

How do I buy shares of NOVOZYMES A/S/S?

Shares of NVZMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NOVOZYMES A/S/S's stock price today?

One share of NVZMY stock can currently be purchased for approximately $42.86.

How big of a company is NOVOZYMES A/S/S?

NOVOZYMES A/S/S has a market capitalization of $12.73 billion and generates $2.28 billion in revenue each year. The biotechnology company earns $511 million in net income (profit) each year or $1.75 on an earnings per share basis. NOVOZYMES A/S/S employs 6,427 workers across the globe.View Additional Information About NOVOZYMES A/S/S.

What is NOVOZYMES A/S/S's official website?

The official website for NOVOZYMES A/S/S is http://www.novozymes.com/.

How can I contact NOVOZYMES A/S/S?

NOVOZYMES A/S/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The biotechnology company can be reached via phone at 45-4446-0000 or via email at [email protected]


MarketBeat Community Rating for NOVOZYMES A/S/S (OTCMKTS NVZMY)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  100 (Thanks for Voting!)
Underperform Votes:  190 (Thanks for Voting!)
Total Votes:  290
MarketBeat's community ratings are surveys of what our community members think about NOVOZYMES A/S/S and other stocks. Vote "Outperform" if you believe NVZMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVZMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel